Grigg Jasmin, Manning Victoria, Lockie Darren, Giles Michelle, Bell Robin, Stragalinos Peta, Bernard Chloe, Volpe Isabelle, Greenwood Christopher J, Smith Liam, Bragge Peter, Lubman Dan I
Turning Point, Eastern Health, Melbourne, Australia.
Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Australia.
JMIR Res Protoc. 2023 Mar 30;12:e44867. doi: 10.2196/44867.
Alcohol consumption is a major modifiable risk factor for female breast cancer, even in small amounts. However, awareness of this risk remains low. National breast screening programs are uniquely positioned to provide timely and targeted health information and behavior change strategies to improve alcohol literacy and reduce consumption. A breast screening service is a novel health care setting for brief alcohol intervention, with the potential for extensive reach.
This study aimed to conduct a formative evaluation with breast screening service consumers to understand the need for, and acceptability of, brief alcohol intervention in the breast screening setting and collaboratively design a brief alcohol intervention (Health4Her); to test the effectiveness of Health4Her in improving knowledge of alcohol as a breast cancer risk factor (primary outcome), improving alcohol literacy, and reducing consumption among women attending a breast screening service; and to examine the implementation strategy through process evaluation.
This was a hybrid type II effectiveness-implementation trial comprising a randomized controlled trial (RCT) alongside a mixed methods program evaluation guided by applicable elements of the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework and Consolidated Framework for Implementation Research. Formative evaluation comprised a retrospective analysis of alcohol consumption data (n=49,240), a web-based survey (n=391), and focus groups and interviews (n=31) with breast screening service consumers. Women attending routine mammography, drinking at any level, were recruited to the single-site, double-blind RCT (n=558), and completed a baseline assessment before randomization (1:1) to receive Health4Her (alcohol brief intervention + lifestyle information) or control (lifestyle information) via animation on an iPad. Follow-up assessments were performed 4 and 12 weeks after randomization. The process evaluation included evaluation of trial administrative data, participant quantitative (n=497) and qualitative feedback (n=30), and site staff qualitative feedback (n=11).
This research was funded in March and May 2019. Data collection for the formative evaluation and trial recruitment occurred between January and April 2020 and February and August 2021, respectively, with finalization of follow-up data collection in December 2021. Quantitative process evaluation data were collected during trial implementation, and collection of participant and staff feedback was finalized in December 2021. Results of the retrospective analysis of alcohol consumption data from breast screening service consumers is anticipated to be published in March 2023 and the results of the RCT to be published in March 2023.
This study is anticipated to generate new substantial knowledge on the alcohol consumption and literacy needs of women attending breast screening and the extent to which these can be addressed using a novel, tailored brief alcohol intervention. The study design permits the evaluation of the effectiveness and implementation of Health4Her to predict and facilitate uptake in breast screening services.
ClinicalTrials.gov NCT04715516; https://clinicaltrials.gov/ct2/show/NCT04715516.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/44867.
饮酒是女性乳腺癌的一个主要可改变风险因素,即使少量饮酒也是如此。然而,对这一风险的认知仍然很低。国家乳房筛查项目具有独特的优势,能够提供及时且有针对性的健康信息和行为改变策略,以提高饮酒知识水平并减少饮酒量。乳房筛查服务是进行简短酒精干预的一种新型医疗环境,具有广泛覆盖的潜力。
本研究旨在对乳房筛查服务的消费者进行形成性评估,以了解在乳房筛查环境中进行简短酒精干预的必要性和可接受性,并共同设计一种简短酒精干预措施(Health4Her);测试Health4Her在提高女性对饮酒作为乳腺癌风险因素的认识(主要结局)、提高饮酒知识水平以及减少参加乳房筛查服务的女性饮酒量方面的有效性;并通过过程评估来检验实施策略。
这是一项II型混合有效性-实施试验,包括一项随机对照试验(RCT)以及一项混合方法的项目评估,该评估由“覆盖、有效性、采用、实施和维持”框架及实施研究综合框架的适用要素指导。形成性评估包括对饮酒数据(n = 49,240)的回顾性分析、一项基于网络的调查(n = 391)以及与乳房筛查服务消费者进行的焦点小组讨论和访谈(n = 31)。参加常规乳房X光检查且有任何饮酒行为的女性被招募到单中心、双盲RCT(n = 558)中,并在随机分组(1:1)前完成基线评估,通过iPad上的动画接受Health4Her(酒精简短干预 + 生活方式信息)或对照(生活方式信息)。随机分组后4周和12周进行随访评估。过程评估包括对试验管理数据、参与者定量反馈(n = 497)和定性反馈(n = 30)以及现场工作人员定性反馈(n = 11)的评估。
本研究于2019年3月和5月获得资助。形成性评估的数据收集和试验招募分别在2020年1月至4月以及2021年2月至8月进行,随访数据收集于2021年12月完成。定量过程评估数据在试验实施期间收集,参与者和工作人员反馈的收集于2021年12月完成。乳房筛查服务消费者饮酒数据回顾性分析的结果预计于2023年3月发表,RCT结果预计于2023年3月发表。
本研究预计将产生关于参加乳房筛查的女性饮酒情况和饮酒知识需求以及使用一种新颖、量身定制的简短酒精干预措施能够满足这些需求程度的新的重要知识。该研究设计允许对Health4Her的有效性和实施情况进行评估,以预测并促进其在乳房筛查服务中的应用。
ClinicalTrials.gov NCT04715516;https://clinicaltrials.gov/ct2/show/NCT04715516。
国际注册报告标识符(IRRID):RR1-10.2196/44867。